Global Natural Killer (NK) Cell Therapeutics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

REPORT SUMMARY
TABLE OF CONTENTS

The Natural Killer (NK) Cell Therapeutics Market is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Natural Killer (NK) Cell Therapeutics market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Natural Killer (NK) Cell Therapeutics industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Natural Killer (NK) Cell Therapeutics Market Segmentations:

By Players:
- Sorrento Therapeutics Inc (USA)
- Innate Pharma SA (France)
- NKT Therapeutics (USA)
- Bristol-Myers Squibb (USA)
- Chipscreen Biosciences (China)
- NantKwest Inc (USA)
- Affimed NV (Netherlands)
- Altor BioScience Corporation (USA)
- Takeda Pharmaceutical (Japan)
By Types:
- Mogamulizumab
- Lorvotuzumab Mertansine
- Others
By End-User:
- Cancer
- Cardiovascular Diseases
- Others
By Regions:

North America
- United States
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
- Spain
- Belgium
- Poland
- Russia
- Turkey
- Others
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia and New Zealand
- ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)
Latin America, Middle East & Africa
- GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
- Brazil
- Nigeria
- South Africa
- Argentina
- Others
Table of Contents
1 Report Overview
- 1.1 Product Definition and Scope
- 1.2 PEST (Political, Economic, Social and Technological) Analysis of Natural Killer (NK) Cell Therapeutics Market
- 1.3 Market Segmentation by Type
- 1.4 Market Segmentation by End-Users
- 1.5 Market Segmentation by Regions
2 Market Trends and Competitive Landscape
- 2.1 Market Trends and Dynamics
- 2.2 Competitive Landscape Analysis
3 Segmentation of Natural Killer (NK) Cell Therapeutics Market by Types
- 3.1 Product Development Trends of Different Types
- 3.2 Commercial Product Types of Major Vendors
- 3.3 Competitive Landscape Analysis of Different Types
- 3.4 Market Size of Natural Killer (NK) Cell Therapeutics by Major Types
4 Segmentation of Natural Killer (NK) Cell Therapeutics Market by End-Users
- 4.1 Downstream Client Analysis by End-Users
- 4.2 Competitive Landscape Analysis of Different End-Users
- 4.3 Market Potential Analysis of Different End-Users
- 4.4 Market Size of Natural Killer (NK) Cell Therapeutics by Major End-Users
5 Market Analysis by Major Regions
- 5.1 Global Natural Killer (NK) Cell Therapeutics Production Analysis by Major Regions
- 5.2 Global Natural Killer (NK) Cell Therapeutics Consumption Analysis by Major Regions
- 5.3 Global Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis by Regions
6 Product Commodity of Natural Killer (NK) Cell Therapeutics Market in Major Countries
- 6.1 Top 5 Export Countries in Natural Killer (NK) Cell Therapeutics market from 2014 to 2019
- 6.2 Top 5 Import Countries in Natural Killer (NK) Cell Therapeutics market from 2014 to 2019
- 6.3 Emerging Top 3 Export Countries Analysis
- 6.4 Emerging Top 3 Import Countries Analysis
7 North America Natural Killer (NK) Cell Therapeutics Landscape Analysis
- 7.1 North America Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types
- 7.2 North America Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users
- 7.3 North America Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Countries
8 Europe Natural Killer (NK) Cell Therapeutics Landscape Analysis
- 8.1 Europe Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types
- 8.2 Europe Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users
- 8.3 Europe Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Countries
9 Asia Pacific Natural Killer (NK) Cell Therapeutics Landscape Analysis
- 9.1 Asia Pacific Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types
- 9.2 Asia Pacific Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users
- 9.3 Asia Pacific Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Countries
10 Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Landscape Analysis
- 10.1 Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Types
- 10.2 Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major End-Users
- 10.3 Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Landscape Analysis by Major Countries
11 Major Players Profile
- 11.1 Sorrento Therapeutics Inc (USA)
- 11.2 Innate Pharma SA (France)
- 11.3 NKT Therapeutics (USA)
- 11.4 Bristol-Myers Squibb (USA)
- 11.5 Chipscreen Biosciences (China)
- 11.6 NantKwest Inc (USA)
- 11.7 Affimed NV (Netherlands)
- 11.8 Altor BioScience Corporation (USA)
- 11.9 Takeda Pharmaceutical (Japan)
12 Data Source and Research Methodology
The List of Tables and Figures (Totals 121 Figures and 134 Tables)
- Figure Product Picture
- Figure Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Mogamulizumab from 2014 to 2026
- Figure Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Lorvotuzumab Mertansine from 2014 to 2026
- Figure Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Others from 2014 to 2026
- Figure Market Share by Type in 2014
- Figure Market Share by Type in 2018
- Figure Market Share by Type in 2026
- Figure Global Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Cancer from 2014 to 2026
- Figure Global Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026
- Figure Global Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Others from 2014 to 2026
- Figure Market Share by End-User in 2014
- Figure Market Share by End-User in 2018
- Figure Market Share by End-User in 2026
- Figure North America Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure United States Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Canada Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Mexico Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Germany Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure UK Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure France Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Italy Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Nordic Countries Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Spain Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Belgium Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Poland Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Russia Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Turkey Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Asia-Pacific Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure China Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Japan Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Australia and New Zealand Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure India Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure ASEAN Countries Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure South Korea Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure GCC Countries Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Brazil Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Nigeria Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure South Africa Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Argentina Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
- Figure Development Trends and Industry Dynamics of Natural Killer (NK) Cell Therapeutics Industry
- Figure Market Challenges and Restraints
- Figure Market Opportunities and Potentials
- Table Mergers and Acquisition
- Figure Market Share of TOP 3 Players in 2018
- Figure Market Share of TOP 5 Players in 2018
- Figure Market Share of TOP 6 Players from 2014 to 2019
- Figure Porter's Five Forces Analysis
- Figure New Entrant SWOT Analysis
- Table Specifications of Different Types of Natural Killer (NK) Cell Therapeutics
- Figure Development Trends of Different Types
- Table Commercial Products Types of Major Vendors
- Figure Competitive Landscape Analysis of Different Types
- Table Consumption of Natural Killer (NK) Cell Therapeutics by Different Types from 2014 to 2026
- Table Consumption Share of Natural Killer (NK) Cell Therapeutics by Different Types from 2014 to 2026
- Figure Market Size and Growth Rate of Mogamulizumab
- Figure Market Size and Growth Rate of Lorvotuzumab Mertansine
- Figure Market Size and Growth Rate of Others
- Table Downstream Client Analysis by End-Users
- Figure Competitive Landscape Analysis of Different End-Users
- Table Market Potential Analysis of Different End-Users
- Table Consumption of Natural Killer (NK) Cell Therapeutics by Different End-Users from 2014 to 2026
- Table Consumption Share of Natural Killer (NK) Cell Therapeutics by Different End-Users from 2014 to 2026
- Figure Market Size and Growth Rate of Cancer
- Figure Market Size and Growth Rate of Cardiovascular Diseases
- Figure Market Size and Growth Rate of Others
- Table Global Natural Killer (NK) Cell Therapeutics Production by Major Regions
- Table Global Natural Killer (NK) Cell Therapeutics Production Share by Major Regions
- Figure Global Natural Killer (NK) Cell Therapeutics Production Share by Major Regions in 2014
- Figure Global Natural Killer (NK) Cell Therapeutics Production Share by Major Regions in 2018
- Figure Global Natural Killer (NK) Cell Therapeutics Production Share by Major Regions in 2026
- Table Global Natural Killer (NK) Cell Therapeutics Consumption by Major Regions
- Table Global Natural Killer (NK) Cell Therapeutics Consumption Share by Major Regions
- Figure Global Natural Killer (NK) Cell Therapeutics Consumption Share by Major Regions in 2014
- Figure Global Natural Killer (NK) Cell Therapeutics Consumption Share by Major Regions in 2018
- Figure Global Natural Killer (NK) Cell Therapeutics Consumption Share by Major Regions in 2026
- Table North America Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis
- Table Europe Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis
- Table Asia Pacific Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis
- Table Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export Analysis
- Table Top 5 Export Countries' Export Value Analysis in Natural Killer (NK) Cell Therapeutics market from 2014 to 2019
- Table Top 5 Export Countries' Export Volume Analysis in Natural Killer (NK) Cell Therapeutics market from 2014 to 2019
- Table Top 5 Import Countries' Import Value Analysis in Natural Killer (NK) Cell Therapeutics market from 2014 to 2019
- Table Top 5 Import Countries' Import Volume Analysis in Natural Killer (NK) Cell Therapeutics market from 2014 to 2019
- Figure Emerging Top 3 Export Countries Analysis
- Figure Emerging Top 3 Import Countries Analysis
- Table North America Natural Killer (NK) Cell Therapeutics Consumption by Types from 2014 to 2026
- Table North America Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2014 to 2026
- Figure North America Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2014
- Figure North America Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2018
- Figure North America Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2026
- Table North America Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2014 to 2026
- Table North America Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2014 to 2026
- Figure North America Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2014
- Figure North America Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2018
- Figure North America Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2026
- Table North America Natural Killer (NK) Cell Therapeutics Consumption by Major Countries from 2014 to 2026
- Table North America Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries from 2014 to 2026
- Figure North America Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries in 2014
- Figure North America Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries in 2018
- Figure North America Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries in 2026
- Figure United States Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure Canada Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure Mexico Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Table Europe Natural Killer (NK) Cell Therapeutics Consumption by Types from 2014 to 2026
- Table Europe Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2014 to 2026
- Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2014
- Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2018
- Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2026
- Table Europe Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2014 to 2026
- Table Europe Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2014 to 2026
- Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2014
- Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2018
- Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2026
- Table Europe Natural Killer (NK) Cell Therapeutics Consumption by Major Countries from 2014 to 2026
- Table Europe Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries from 2014 to 2026
- Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries in 2014
- Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries in 2018
- Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries in 2026
- Figure Germany Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure UK Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure France Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure Italy Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure Nordic Countries Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure Belgium Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure Poland Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure Russia Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure Turkey Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Table Asia Pacific Natural Killer (NK) Cell Therapeutics Consumption by Types from 2014 to 2026
- Table Asia Pacific Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2014 to 2026
- Figure Asia Pacific Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2014
- Figure Asia Pacific Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2018
- Figure Asia Pacific Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2026
- Table Asia Pacific Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2014 to 2026
- Table Asia Pacific Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2014 to 2026
- Figure Asia Pacific Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2014
- Figure Asia Pacific Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2018
- Figure Asia Pacific Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2026
- Table Asia Pacific Natural Killer (NK) Cell Therapeutics Consumption by Major Countries from 2014 to 2026
- Table Asia Pacific Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries from 2014 to 2026
- Figure Asia Pacific Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries in 2014
- Figure Asia Pacific Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries in 2018
- Figure Asia Pacific Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries in 2026
- Figure China Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure Japan Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure Australia and New ZealandNatural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure India Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure ASEAN Countries Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure South Korea Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Table Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Types from 2014 to 2026
- Table Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Share by Types from 2014 to 2026
- Figure Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2014
- Figure Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2018
- Figure Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Share by Types in 2026
- Table Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by End-Users from 2014 to 2026
- Table Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users from 2014 to 2026
- Figure Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2014
- Figure Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2018
- Figure Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Share by End-Users in 2026
- Table Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Major Countries from 2014 to 2026
- Table Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries from 2014 to 2026
- Figure Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries in 2014
- Figure Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries in 2018
- Figure Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Share by Major Countries in 2026
- Figure GCC Countries Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure Brazil Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure Nigeria Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure South Africa Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Figure Argentina Natural Killer (NK) Cell Therapeutics Market Volume and Growth Rate from 2014 to 2026
- Table Company Profile and Development Status of Sorrento Therapeutics Inc (USA)
- Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sorrento Therapeutics Inc (USA)
- Figure Sales and Growth Rate Analysis of Sorrento Therapeutics Inc (USA)
- Figure Revenue and Market Share Analysis of Sorrento Therapeutics Inc (USA)
- Table Product and Service Introduction of Sorrento Therapeutics Inc (USA)
- Table Company Profile and Development Status of Innate Pharma SA (France)
- Table Sales, Revenue, Sales Price and Gross Margin Analysis of Innate Pharma SA (France)
- Figure Sales and Growth Rate Analysis of Innate Pharma SA (France)
- Figure Revenue and Market Share Analysis of Innate Pharma SA (France)
- Table Product and Service Introduction of Innate Pharma SA (France)
- Table Company Profile and Development Status of NKT Therapeutics (USA)
- Table Sales, Revenue, Sales Price and Gross Margin Analysis of NKT Therapeutics (USA)
- Figure Sales and Growth Rate Analysis of NKT Therapeutics (USA)
- Figure Revenue and Market Share Analysis of NKT Therapeutics (USA)
- Table Product and Service Introduction of NKT Therapeutics (USA)
- Table Company Profile and Development Status of Bristol-Myers Squibb (USA)
- Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb (USA)
- Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb (USA)
- Figure Revenue and Market Share Analysis of Bristol-Myers Squibb (USA)
- Table Product and Service Introduction of Bristol-Myers Squibb (USA)
- Table Company Profile and Development Status of Chipscreen Biosciences (China)
- Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chipscreen Biosciences (China)
- Figure Sales and Growth Rate Analysis of Chipscreen Biosciences (China)
- Figure Revenue and Market Share Analysis of Chipscreen Biosciences (China)
- Table Product and Service Introduction of Chipscreen Biosciences (China)
- Table Company Profile and Development Status of NantKwest Inc (USA)
- Table Sales, Revenue, Sales Price and Gross Margin Analysis of NantKwest Inc (USA)
- Figure Sales and Growth Rate Analysis of NantKwest Inc (USA)
- Figure Revenue and Market Share Analysis of NantKwest Inc (USA)
- Table Product and Service Introduction of NantKwest Inc (USA)
- Table Company Profile and Development Status of Affimed NV (Netherlands)
- Table Sales, Revenue, Sales Price and Gross Margin Analysis of Affimed NV (Netherlands)
- Figure Sales and Growth Rate Analysis of Affimed NV (Netherlands)
- Figure Revenue and Market Share Analysis of Affimed NV (Netherlands)
- Table Product and Service Introduction of Affimed NV (Netherlands)
- Table Company Profile and Development Status of Altor BioScience Corporation (USA)
- Table Sales, Revenue, Sales Price and Gross Margin Analysis of Altor BioScience Corporation (USA)
- Figure Sales and Growth Rate Analysis of Altor BioScience Corporation (USA)
- Figure Revenue and Market Share Analysis of Altor BioScience Corporation (USA)
- Table Product and Service Introduction of Altor BioScience Corporation (USA)
- Table Company Profile and Development Status of Takeda Pharmaceutical (Japan)
- Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical (Japan)
- Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical (Japan)
- Figure Revenue and Market Share Analysis of Takeda Pharmaceutical (Japan)
- Table Product and Service Introduction of Takeda Pharmaceutical (Japan)

Natural Killer (NK) Cell Therapeutics Market Report

Global Natural Killer (NK) Cell Therapeutics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

1 Report Overview

2 Market Trends and Competitive Landscape

3 Segmentation of Natural Killer (NK) Cell Therapeutics Market by Types

4 Segmentation of Natural Killer (NK) Cell Therapeutics Market by End-Users

5 Market Analysis by Major Regions

6 Product Commodity of Natural Killer (NK) Cell Therapeutics Market in Major Countries

7 North America Natural Killer (NK) Cell Therapeutics Landscape Analysis

8 Europe Natural Killer (NK) Cell Therapeutics Landscape Analysis

9 Asia Pacific Natural Killer (NK) Cell Therapeutics Landscape Analysis

10 Latin America, Middle East & Africa Natural Killer (NK) Cell Therapeutics Landscape Analysis

11 Major Players Profile

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 121 Figures and 134 Tables)

Report Version Choose

Our Customers

Beyond Consulting, Future is Feasible

Quick Link

CONTACT US